Showing 931-940 of 1204 results for "".
- Kenvue to Showcase 22 New Sets of Clinical Data at AADhttps://modernaesthetics.com/news/kenvue-to-showcase-22-new-sets-of-clinical-data-at-aad/2473552/Kenvue announced it will share 22 data sets detailing new Kenvue skin science research at the American Academy of Dermatology (AAD) Association annual meeting, March 8-12, in San Diego. Evidence will be presented on the clinical effectiveness of Neutrogena and Aveeno
- Trufacial Touts Survey Showing High Satisfaction with Facial Rejuvenation Systemhttps://modernaesthetics.com/news/trufacial-survery-results/2473550/A market survey of 100 female consumers revealed that 100% of participants found the skin-perfecting TrufacialTM hand-held device not only met their skincare needs, but also exceeded expectations after only
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a
- Beauty and Self-Care Brands Announce Rennaï Spotshttps://modernaesthetics.com/news/beauty-and-self-care-brands-announce-rennai-spots/2473546/Rennaï, a new beauty and self-care retail concept in Montreal, announced that luxury global brand Hermes will be joining world-renowned professional-grade skin care brand Dermalogica at its flagship location at Royalmount. The combination of coveted luxury brands, ma
- Tracking Trends in Breast Implant Surgery Techniques From 2005 to 2020https://modernaesthetics.com/news/tracking-trends-in-breast-implant-surgery-techniques-from-2005-to-2020/2473538/Breast implant placement with inframammary incisions increased from 68% to 80%, while use of peri-areolar incisions decreased from 24% to 14% between 2005 and 2020, according to a study in the December 2023 issue of Plastic and Reconstruct
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com
- Industry Vet Matthew Hill Named CFO at Apyx Medical Corporationhttps://modernaesthetics.com/news/industry-vet-matthew-hill-named-cfo-at-apyx-medical-corporation/2473534/Matthew Hill is Apyx Medical Corporation’s (new Chief Financial Officer (CFO), effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. “With its innovative Renuvion technology, large, global m
- The Art of Saying Nohttps://modernaesthetics.com/news/the-art-of-saying-no/2473533/Most cosmetic dermatologists and plastic surgeons have encountered a patient (or patients) with unreasonable expectations and know intuitively that these patients won’t be satisfied with the outcome of a requested procedure. Still, it can be hard to say no, especially when the doc
- Allergan Aesthetics and The Black Beauty Club Partner to Foster Diversity in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-x-the-black-beauty-club-partner-to-advance-diversity-in-aesthetics/2473531/Allergan Aesthetics joined forces with the Black Beauty Club for a consumer initiative to spark open dialogue and empower Black individuals to embrace their unique beauty and make informed decisions about their aesthetic care. The event, which took place in Atlanta on Novembe
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o